# Southern Consortium Node of the Clinical Trials Network

> **NIH NIH UG1** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2020 · $545,917

## Abstract

Abstract
 The Southern Consortium Node (SCN) has been an integral part of the NIDA-funded Clinical Trials
Network (CTN) consortium since 2000, evolving to meet changing CTN needs and leading and contributing to a
portfolio of compelling addiction science and treatment research projects with outstanding performance metrics.
We have expanded our network throughout the Southeast and established close and collaborative working
relationships with a diverse and geographically dispersed group of programs including primary care and medical
specialty practices. We have a cost-effective system for accessing specialized expertise for specific CTN trials.
We have solid collaborative relationships with community substance use disorder (SUD) treatment programs,
primary care providers and governmental agencies that facilitate research, implementation and dissemination
efforts. Our CTN efforts are complemented and enhanced by our statewide CTSA infrastructure, creating a
research capacity that extends far beyond our academic home.
 For this renewal, we propose to further expand our network to include six rural states in the Southeast
with a research agenda focused on best practices for bringing evidence-based care to underserved rural
populations across the full continuum of care. We will develop a Health Technology Core to facilitate exploration
of the use of technology to address health disparities in SUD treatment. We will develop an Implementation
Science Core and employ Learning Health System principles to move positive findings into our partnering
practice systems, fulfilling the core CTN mission of moving evidence-based treatment beyond academic settings.
 In sum, the SCN has demonstrated remarkable flexibility, creativity and the collaborative and innovative
spirit required to meet new challenges and take advantage of growing CTN opportunities. We have gathered a
multidisciplinary team with expertise in addiction psychiatry, clinical research, informatics, analytics, healthcare
technology, dissemination and implementation science. We will employ our resources and expertise in
innovative areas to address identified gaps in access, engagement and retention in treatment for individuals with
SUDs. The SCN team looks forward to continued participation in the CTN consortium.

## Key facts

- **NIH application ID:** 10163408
- **Project number:** 3UG1DA013727-21S1
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** KATHLEEN T. BRADY
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $545,917
- **Award type:** 3
- **Project period:** 2000-09-30 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10163408

## Citation

> US National Institutes of Health, RePORTER application 10163408, Southern Consortium Node of the Clinical Trials Network (3UG1DA013727-21S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10163408. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*